Breaking News in Spinal Cord Injury Research: FDA Approved Phase I Clinical Trial of Human, Autologous Schwann Cell Transplantation in Patients with Spinal Cord Injuries
Main Author: | Xu, Xiao-Ming |
---|---|
Format: | Online |
Language: | English |
Published: |
Medknow Publications & Media Pvt Ltd
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302447/ |
Similar Items
-
Clinical translation of autologous Schwann cell transplantation for the treatment of spinal cord injury
by: Guest, James, et al.
Published: (2013) -
Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery
by: Colón, Jennifer M., et al.
Published: (2016) -
Role of endogenous Schwann cells in tissue repair after spinal cord injury☆
by: Zhang, Shu-xin, et al.
Published: (2013) -
Hypothermia in spinal cord injury
by: Castillo-Abrego, Guadalupe A
Published: (2012) -
Melatonin for the treatment of spinal cord injury
by: Yan Zhang, et al.
Published: (2018-01-01)